Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis

Frontiers in Pediatrics - Switzerland
doi 10.3389/fped.2019.00568
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Intravenous Paracetamol and Patent Ductus Arteriosus Closure in Preterm Infants

Paediatrica Indonesiana
2017English

Overview of Transcatheter Patent Ductus Arteriosus Closure in Preterm Infants

Congenital Heart Disease
Nuclear MedicineRadiologyPediatricsCardiologyPerinatologyCardiovascular MedicineImagingMedicineChild HealthSurgery
2019English

Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants

Journal of Pediatrics
Child HealthPediatricsPerinatology
2016English

Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants

Journal of Pediatrics
Child HealthPediatricsPerinatology
2017English

Efficacy of Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2014English

Intravenous Paracetamol (Acetaminophen) for Patent Ductus Arteriosus Closure in Premature Infants ≤ 32 Weeks’ Gestation

Gaceta Medica de Mexico
Medicine
2019English

Our Anesthetic Results in Preterm Infants Undergoing Patent Ductus Arteriosus LigationOur Anesthetic Results in Preterm Infants Undergoing Patent Ductus Arteriosus Ligation

Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi
AnesthesiologyPain Medicine
2017English

Thoracotomy Versus Sternotomy for Patent Ductus Arteriosus Closure in Preterm Neonates

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2020English

Efficacy of Paracetamol in Closure of Ductus Arteriosus in Infants Under 32 Weeks of Gestation

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy